2SINGHAL S, MEHTA J, DESIKAN R, et al.Antiumor activity of thalidomide in refractory multiple myeloma[J].N Engl J Med,1999,341(21) : 1565.
3RAJKUMAR S V, WITZIG T E. A review of angigenesis and antiangiogenie therapy with thalidomide in multiple myeloma[J]. Cancer Treat Rev,2000,26:351-362.
4RAJKUMAR S V, LEONG T, ROCHE P C, et al. Prognostic value of bone marrow angiogensis in multiple myeloma [J]. Clin Cancer Rev,2000,6:3111-3116.
5GUNNAR J, FREDRIK C. Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma [J]. Br J Haematol,2000,109(1) :89-96.